Europe Pharma Heavyweights Call For Higher Drug Prices At Home

Sanofi's Paul Hudson and Novartis's Vas Narasimhan claim that while Europe is home to some of the most important biopharma companies in the world, its position is in jeopardy.

Paul Hudson and Vas Narasimhan
Paul Hudson (L) and Vas Narasimhan (Illustration by Kosh Naran)

More from Manufacturing

More from Market Access